NBP in Adult Patients With Acute Ischemic Stroke (AIS)
Status:
Completed
Trial end date:
2020-08-07
Target enrollment:
Participant gender:
Summary
This is a Phase 2 multicenter, randomized, double-blind, placebo-controlled, add-on to
standard of care study of NBP softgel capsules for the treatment of mild to moderate AIS in
adults.